NEW YORK, Dec. 8, 2010 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Astellas Pharma Inc.: PharmaVitae Profile
http://www.reportlinker.com/p0110534/Astellas-Pharma-Inc-PharmaVitae-Profile.html
IntroductionThis analysis examines the historical and
forecast performance for Astellas in the prescription
pharmaceutical sector. The profile encompasses global company
strategy, portfolio and pipeline analysis and assessment of
financial performance, with 1-6 year sales forecasts for key
drugs.
Features and benefitsGain insight into Astellas’s strategic
outlook across the next 6 years
Analyze company sales forecasts by product, therapy area,
lifecycle stage, geography, molecule type and source
Highlights
Strategic insight into the prospects for Astellas over the
next six years. Picking out key strengths, weaknesses,
opportunities and threats and evaluating the company’s prescription
pharmaceuticals outlook using a variety of cuts of the historical
and forecast sales.
Your key questions answeredBenchmark Astellas’s performance
against key rivals in the prescription pharmaceutical
sector
Determine whether Astellas’s pipeline will be able to offset
the sharp decline facing its marketed portfolio
To order this report::
Astellas Pharma Inc.: PharmaVitae Profile
Check our
SOURCE